The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca says it’ll invest $50 billion in the United States by 2030 as President Donald Trump threatens steep tariffs on drug imports. The pharmaceutical giant Astra Zeneca has announced it's to ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

President Donald Trump announced on Monday that British-Swedish drugmaker AstraZeneca will be investing $50 billion in the ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

The pharmaceutical company is accelerating its expansion in the country as President Donald Trump considers tariffs of up to ...